Outlook Wealth Advisors LLC Buys Shares of 2,887 STERIS plc $STE

Outlook Wealth Advisors LLC purchased a new stake in STERIS plc (NYSE:STE) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 2,887 shares of the medical equipment provider’s stock, valued at approximately $714,000.

A number of other institutional investors have also added to or reduced their stakes in STE. Jones Financial Companies Lllp lifted its holdings in shares of STERIS by 46.1% in the first quarter. Jones Financial Companies Lllp now owns 1,106 shares of the medical equipment provider’s stock worth $251,000 after buying an additional 349 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in STERIS by 32.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 242,732 shares of the medical equipment provider’s stock worth $55,015,000 after acquiring an additional 59,264 shares during the period. Empowered Funds LLC lifted its stake in STERIS by 16.1% in the 1st quarter. Empowered Funds LLC now owns 2,303 shares of the medical equipment provider’s stock worth $522,000 after purchasing an additional 319 shares in the last quarter. Woodline Partners LP boosted its holdings in STERIS by 40.0% in the 1st quarter. Woodline Partners LP now owns 8,300 shares of the medical equipment provider’s stock valued at $1,881,000 after purchasing an additional 2,372 shares during the period. Finally, Jane Street Group LLC grew its position in shares of STERIS by 38.9% during the 1st quarter. Jane Street Group LLC now owns 20,716 shares of the medical equipment provider’s stock valued at $4,695,000 after purchasing an additional 5,803 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

STERIS Stock Up 1.2%

STE opened at $261.16 on Thursday. STERIS plc has a 12 month low of $204.90 and a 12 month high of $269.44. The company has a current ratio of 2.37, a quick ratio of 1.63 and a debt-to-equity ratio of 0.27. The business’s 50-day moving average price is $258.82 and its 200-day moving average price is $247.19. The company has a market cap of $25.63 billion, a P/E ratio of 37.52 and a beta of 1.03.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, topping analysts’ consensus estimates of $2.38 by $0.09. STERIS had a return on equity of 14.43% and a net margin of 12.07%.The business had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same period in the previous year, the firm earned $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. On average, equities analysts expect that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Investors of record on Tuesday, November 18th were issued a dividend of $0.63 per share. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date was Tuesday, November 18th. STERIS’s payout ratio is currently 36.21%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a research report on Friday, January 9th. Seven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $273.50.

Insiders Place Their Bets

In related news, VP Renato Tamaro sold 5,036 shares of STERIS stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total value of $1,297,021.80. Following the sale, the vice president owned 5,695 shares in the company, valued at $1,466,747.25. The trade was a 46.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Julia Madsen sold 5,008 shares of the business’s stock in a transaction on Friday, November 21st. The shares were sold at an average price of $262.00, for a total transaction of $1,312,096.00. Following the transaction, the vice president directly owned 10,710 shares in the company, valued at approximately $2,806,020. The trade was a 31.86% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 25,044 shares of company stock worth $6,586,218. 1.07% of the stock is currently owned by company insiders.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.